Q3 2024 · 13F-HR
Ally Bridge Group (NY) LLCholdings as filed
Filed 2024-11-14 · accession 0000950123-24-011470
$186.8M
Reported value
29
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 457669307 | INSM | INSMED INC | $11.0M | 5.89% | 150,833 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $10.6M | 5.67% | 321,898 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $10.4M | 5.57% | 208,244 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $9.9M | 5.32% | 263,266 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $9.8M | 5.25% | 106,080 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $9.0M | 4.81% | 72,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $8.3M | 4.46% | 211,791 | Common | SOLE |
| 54300N103 | — | LONGBOARD PHARMACEUTICALS IN | $8.0M | 4.30% | 240,892 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $7.5M | 4.02% | 399,466 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $7.4M | 3.97% | 163,500 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $7.3M | 3.91% | 227,700 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $6.3M | 3.40% | 270,075 | Common | SOLE |
| 28658R106 | CLYM | ELIEM THERAPEUTICS INC | $6.3M | 3.35% | 1,229,292 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $6.0M | 3.23% | 1,331,053 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $6.0M | 3.21% | 234,856 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $5.7M | 3.08% | 294,081 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $5.3M | 2.81% | 618,332 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $5.0M | 2.68% | 187,695 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS | $5.0M | 2.65% | 309,614 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $4.9M | 2.65% | 108,811 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $4.9M | 2.63% | 100,000 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $4.6M | 2.44% | 341,739 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $4.5M | 2.40% | 788,508 | Common | SOLE |
| 022307102 | ALMS | ALUMIS INC | $4.5M | 2.39% | 418,416 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $4.4M | 2.37% | 626,058 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $4.4M | 2.37% | 1,322,800 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $4.2M | 2.25% | 73,185 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $3.4M | 1.84% | 1,757,524 | Common | SOLE |
| 74346M406 | PMNEUR | PROMIS NEUROSCIENCES INC | $2.0M | 1.07% | 1,592,605 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.